“Znomics moves to revolutionize drug discovery as we know it…delivering (preclinical) compounds in the next three years… for billion dollar markets.”

Anthony Haddad
Equities Magazine
September 2008
[Read more...]

Transforming Drug Discovery

Znomics, Inc. is leading a transformation in drug discovery by combining medicinal chemistry with zebrafish technologies. Our research programs aim to discover new drugs to treat inflammation, osteoporosis, metabolic diseases and others.

Despite several decades of extraordinary advances in biotechnology, it has become increasingly more difficult and expensive for large Pharma companies to bring new drugs to market to treat human disorders and diseases. Znomics, Inc. delivers an innovative approach to whole animal compound screening that is less costly, faster and more powerful than traditional single-target screening for drug discovery. Our proprietary technologies for improving drug discovery promise to make drug discovery more efficient and more successful, leading to a new era in drug discovery research

[Learn more about Znomics...]

Znomics News

December 10, 2008

Read the December letter to shareholders from CEO Mark Philip [Read more...]

October 13, 2008
Znomics, Inc. Builds Patent Estate for Proprietary Zebrafish Technologies. [Read more...]

October 13, 2008
Znomics, Inc. Announces Purchase of $50,000 of Its Common Stock by Directors and Officers. [Read more...]

Read a Znomics newsletter to shareholders from CEO Mark Philip describing our recent progress.

[Read more Znomics news...]